Amryt Pharma Plc ADR (AMYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AMYT | URGN | PCRX | ||
| Company | Amryt Pharma Plc ADR | Urogen Pharma Ltd | Pacira Pharm Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 14.71 | 19.01 | 22.29 | ||
| High | 14.76 | 19.24 | 22.89 | ||
| Low | 14.63 | 18.54 | 22.15 | ||
| Latest | 14.70 | 18.84 | 22.83 | ||
| Change | +0.01 | -0.61 | +0.39 | ||
| % Change | +0.07% | -3.14% | +1.74% | ||
| Volume | 2,389,400 | 453,000 | 554,400 | ||
| 20-Day Average Volume | 650,490 | 931,590 | 892,370 | ||
| Previous Close | 14.69 | 19.45 | 22.44 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 14.59 | 20.43 | 22.51 | ||
| 20-Day Raw Stochastic | 75.00% | 17.88% | 71.06% | ||
| 20-Day Relative Strength | 72.77 | 42.94 | 52.55 | ||
| Weighted Alpha | +10.40 | +25.24 | -3.56 | ||
| Today's Opinion | 88% Buy | 24% Sell | 48% Sell | ||
| Previous Opinion | 88% Buy | 24% Sell | 56% Sell | ||
| Last Month's Opinion | 96% Buy | 40% Buy | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.62% since 04/03/23 | -6.55% since 03/04/26 | -0.13% since 03/04/26 | ||
| Low | 14.58 on 04/04/23 | 18.54 on 03/11/26 | 21.49 on 03/06/26 | ||
| High | 14.76 on 04/11/23 | 21.06 on 03/09/26 | 23.28 on 03/05/26 | ||
| 1-Month | |||||
| %Chg | +0.62% since 03/10/23 | -10.88% since 02/11/26 | +5.06% since 02/11/26 | ||
| Low | 14.52 on 03/16/23 | 18.04 on 03/02/26 | 20.62 on 02/27/26 | ||
| High | 14.76 on 04/11/23 | 22.50 on 02/19/26 | 23.73 on 02/26/26 | ||
| 3-Month | |||||
| %Chg | -0.47% since 01/11/23 | -15.74% since 12/11/25 | -11.27% since 12/11/25 | ||
| Low | 14.52 on 03/16/23 | 18.04 on 03/02/26 | 18.80 on 01/20/26 | ||
| High | 14.77 on 01/13/23 | 24.71 on 12/16/25 | 27.16 on 12/16/25 | ||
| 6-Month | |||||
| %Chg | +116.18% since 10/11/22 | -2.13% since 09/11/25 | -15.54% since 09/11/25 | ||
| Low | 6.50 on 10/28/22 | 15.86 on 10/10/25 | 18.80 on 01/20/26 | ||
| High | 14.77 on 01/13/23 | 30.00 on 11/26/25 | 27.50 on 09/15/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 940,256 | 946,865 | 908,596 | ||
| Shares Outstanding, K | 63,963 | 48,682 | 40,490 | ||
| Annual Sales | 222,540,000 | 109,790,000 | 726,410,000 | ||
| Annual Net Income | 1,000,000 | -153,490,000 | 7,030,000 | ||
| Last Quarter Sales | 61,126,000 | 37,840,000 | 196,870,000 | ||
| Last Quarter Net Income | -20,795,000 | -26,360,000 | 1,640,000 | ||
| 60-Month Beta | 0.84 | 1.34 | 0.21 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.06 on 11/03/22 | -0.69 on 11/06/25 | 0.57 on 02/26/26 | ||
| Latest Earnings Date | 05/03/23 | 05/11/26 | 05/14/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 734.50 | 0.00 | 13.56 | ||